Acme offers parents tips to a healthier Halloween
MALVERN, Pa. — A Supervalu banner is offering parents ways to have a healthier Halloween.
Acme Markets registered dietitian Jennifer Shea said that such ideas as making sure children sleep well the night before Halloween, not letting children overindulge and having kids wear a pedometer to track their steps can help make Halloween a healthier holiday.
“Let’s face it, half the fun of Halloween is that it’s a holiday of indulgence and sugary treats,” Shea said. “By planning we can make adjustments in our routine to accommodate a night or two of Halloween trick or treating and fun.”
Shea also suggested offering treats that are more nutritious than candy and other sugary snacks, which can be found at Acme stores with help from the chain’s Nutrition iQ program that features color-coded icons on shelf tags and signs that serve as at-a-glance cues to help shoppers identify and find healthy food options.
“When picking out treats in preparation for Halloween, why not include some that pack a nutrient punch? Like trail mix, mini popcorn bags, yogurt covered raisins, 100% fruit roll-ups, granola bars or sunflower seeds,” Shea said.
Click here for more information.
Mylan gets green light for MS Contin generic
PITTSBURGH — Mylan has received final approval from the Food and Drug Administration for a drug designed to treat moderate to severe pain.
Mylan said its abbreviated new drug application for morphine sulfate extended-release tablets in the 15-mg, 30-mg, 60-mg, 100-mg and 200-mg strengths was approved by the FDA. The opioid analgesic is a generic version of Purdue Pharma’s MS Contin. Mylan said it is launching the product immediately.
Morphine sulfate ER tablets had U.S. sales of approximately $173 million for the 12 months ended in June, according to IMS Health.
Innopharma receives FDA approval for generic Zyprexa injection
PISCATAWAY, N.J. — A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a psychiatric drug.
Innopharma said its abbreviated new drug application for olanzapine injection, a generic equivalent of Zyprexa injection. With this approval, Innopharma announced that it has entered an agreement with Sandoz, who will sell, market and distribute Innopharma’s generic in the United States.
Innopharma joins several other drug makers that received FDA approval earlier this week to market their versions of Zyprexa and Zyprexa Zydus, which are designed to treat schizophrenia and bipolar disorder.